TYK Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2410?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders8,250,0002.22%
Public Companies10,468,5842.82%
Employee Share Scheme31,250,0008.43%
Institutions44,412,65412%
General Public91,036,85724.5%
Private Companies185,417,72350%

Dilution of Shares: 2410 only recently listed within the past 12 months


Top Shareholders

Top 12 shareholders own 75.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
44.5%
Tetranov Pharmaceutical (Zhengzhou) Co., Ltd.
165,000,000HK$5.0b0%no data
8.43%
TYK Medicines, Inc,ESOP
31,250,000HK$954.7m0%no data
4.58%
Changxing Xingchang Industrial Investment Partnership (Limited Partnership)
17,000,000HK$519.4m0%no data
3.81%
Ningbo Meishan Bonded Port Area Houji Tongnuo Investment Management Partnership (Limited Partnership
14,146,619HK$432.2m0%no data
2.82%
Sichuan Huiyu Pharmaceutical Co., Ltd.
10,468,584HK$319.8m0%no data
2.59%
Jiangsu Addor Capital Results Innovation Venture Capital Fund (Limited Partnership)
9,600,000HK$293.3m0%no data
2.22%
Eric Gu
8,250,000HK$252.0m0%no data
1.94%
Jiangsu Addor Equity Investment Fund Management Co., Ltd.
7,200,000HK$220.0m0%13.14%
1.42%
Ningbo Meishan Bonded Port Area Houyang Tongchi Investment Management Partnership (Limited Partnersh
5,258,035HK$160.6m0%no data
1.24%
Zhuzhou Guohai Guochuang Qianjin Pharmaceutical Venture Capital Partnership (Limited Partnership)
4,608,000HK$140.8m0%no data
0.97%
Nanjing Addor Equity Investment Management Enterprise (Limited Partnership)
3,600,000HK$110.0m0%18.87%
0.92%
Houyang Tongchi Investment Management Partnership (Limited Partnership)
3,417,723HK$104.4m0%no data